
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Animal models of cholangiocarcinoma
Emilien Loeuillard, Samantha R. Fischbach, Gregory J. Gores, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1865, Iss. 5, pp. 982-992
Open Access | Times Cited: 71
Emilien Loeuillard, Samantha R. Fischbach, Gregory J. Gores, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1865, Iss. 5, pp. 982-992
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1697
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1697
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 499
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 499
Myricetin: A review of the most recent research
Xiaominting Song, Lu Tan, Miao Wang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 134, pp. 111017-111017
Open Access | Times Cited: 258
Xiaominting Song, Lu Tan, Miao Wang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 134, pp. 111017-111017
Open Access | Times Cited: 258
Animal models for liver disease – A practical approach for translational research
Yulia A. Nevzorova, Zoé Boyer-Díaz, Francisco Javier Cubero, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 423-440
Open Access | Times Cited: 192
Yulia A. Nevzorova, Zoé Boyer-Díaz, Francisco Javier Cubero, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 423-440
Open Access | Times Cited: 192
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
Qianfei Zhang, Chi Ma, Yi Duan, et al.
Cancer Discovery (2020) Vol. 11, Iss. 5, pp. 1248-1267
Open Access | Times Cited: 174
Qianfei Zhang, Chi Ma, Yi Duan, et al.
Cancer Discovery (2020) Vol. 11, Iss. 5, pp. 1248-1267
Open Access | Times Cited: 174
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 89
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 89
Evolution of the Experimental Models of Cholangiocarcinoma
Annamaria Massa, Chiara Varamo, Francesca Vita, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2308-2308
Open Access | Times Cited: 89
Annamaria Massa, Chiara Varamo, Francesca Vita, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2308-2308
Open Access | Times Cited: 89
Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation
Lizhuang Shu, Xingyong Li, Zengli Liu, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 307-322
Closed Access | Times Cited: 32
Lizhuang Shu, Xingyong Li, Zengli Liu, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 307-322
Closed Access | Times Cited: 32
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F. Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 462-480
Open Access | Times Cited: 23
Diego F. Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 462-480
Open Access | Times Cited: 23
Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
Hsing‐Ju Wu, Pei‐Yi Chu
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4154-4154
Open Access | Times Cited: 71
Hsing‐Ju Wu, Pei‐Yi Chu
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4154-4154
Open Access | Times Cited: 71
Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma
Keisaku Sato, Wenjun Zhang, Samira Safarikia, et al.
Hepatology (2020) Vol. 74, Iss. 1, pp. 491-502
Open Access | Times Cited: 51
Keisaku Sato, Wenjun Zhang, Samira Safarikia, et al.
Hepatology (2020) Vol. 74, Iss. 1, pp. 491-502
Open Access | Times Cited: 51
Liver cirrhosis: An overview of experimental models in rodents
Lanuza A.P. Faccioli, Marlon Lemos Dias, Bruno Andrade Paranhos, et al.
Life Sciences (2022) Vol. 301, pp. 120615-120615
Closed Access | Times Cited: 36
Lanuza A.P. Faccioli, Marlon Lemos Dias, Bruno Andrade Paranhos, et al.
Life Sciences (2022) Vol. 301, pp. 120615-120615
Closed Access | Times Cited: 36
Piezo 1 activation facilitates cholangiocarcinoma metastasis via Hippo/YAP signaling axis
Biqiang Zhu, Wei Qian, Chaoqun Han, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 24, pp. 241-252
Open Access | Times Cited: 37
Biqiang Zhu, Wei Qian, Chaoqun Han, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 24, pp. 241-252
Open Access | Times Cited: 37
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Ann‐Kathrin Lederer, Nele Görrissen, Tinh Thi Nguyen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Patient-derived tumor xenograft animal model of gastric cancer in precision chemotherapy
Yiyin Zhang, Yongming Yang, Jiayi Zhou, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Yiyin Zhang, Yongming Yang, Jiayi Zhou, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Clonorchis sinensis and Cholangiocarcinoma
Eun-Min Kim, Sung‐Tae Hong
Journal of Korean Medical Science (2025) Vol. 40
Open Access
Eun-Min Kim, Sung‐Tae Hong
Journal of Korean Medical Science (2025) Vol. 40
Open Access
Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure
Guido Carpino, Diletta Overi, Fabio Melandro, et al.
Clinical Proteomics (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 41
Guido Carpino, Diletta Overi, Fabio Melandro, et al.
Clinical Proteomics (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 41
YAP and the Hippo pathway in cholangiocarcinoma
Takaaki Sugihara, Hajime Isomoto, Gregory J. Gores, et al.
Journal of Gastroenterology (2019) Vol. 54, Iss. 6, pp. 485-491
Open Access | Times Cited: 38
Takaaki Sugihara, Hajime Isomoto, Gregory J. Gores, et al.
Journal of Gastroenterology (2019) Vol. 54, Iss. 6, pp. 485-491
Open Access | Times Cited: 38
Cholangiocarcinoma: novel therapeutic targets
Keisaku Sato, Shannon Glaser, Domenico Alvaro, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 345-357
Open Access | Times Cited: 33
Keisaku Sato, Shannon Glaser, Domenico Alvaro, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 4, pp. 345-357
Open Access | Times Cited: 33
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Leticia Colyn, Gloria Álvarez‐Sola, M. Ujúe Latasa, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Leticia Colyn, Gloria Álvarez‐Sola, M. Ujúe Latasa, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
Zehui Li, Jin Wang, Zhenning Wang, et al.
EBioMedicine (2023) Vol. 92, pp. 104601-104601
Open Access | Times Cited: 12
Zehui Li, Jin Wang, Zhenning Wang, et al.
EBioMedicine (2023) Vol. 92, pp. 104601-104601
Open Access | Times Cited: 12
New and Old Key Players in Liver Cancer
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17152-17152
Open Access | Times Cited: 12
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17152-17152
Open Access | Times Cited: 12
The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies
Haochuan Guo, Xinru Xu, Jiaxi Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 4
Haochuan Guo, Xinru Xu, Jiaxi Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1048-1048
Open Access | Times Cited: 4
Overview of pro-inflammatory and pro-survival components in neuroinflammatory signalling and neurodegeneration
Shefali Kardam, Rashmi K. Ambasta, Pravir Kumar
Ageing Research Reviews (2024) Vol. 100, pp. 102465-102465
Closed Access | Times Cited: 4
Shefali Kardam, Rashmi K. Ambasta, Pravir Kumar
Ageing Research Reviews (2024) Vol. 100, pp. 102465-102465
Closed Access | Times Cited: 4
The utilisation of biliary organoids for biomedical applications
Zhongwen Lei, Yijun Yang, Yang Xiang
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access
Zhongwen Lei, Yijun Yang, Yang Xiang
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access